LABD vs. ARKK
Compare and contrast key facts about Direxion Daily S&P Biotech Bear 3x Shares (LABD) and ARK Innovation ETF (ARKK).
LABD and ARKK are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LABD is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (-300%). It was launched on May 28, 2015. ARKK is an actively managed fund by ARK. It was launched on Oct 31, 2014.
Performance
LABD vs. ARKK - Performance Comparison
Loading graphics...
LABD vs. ARKK - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | -22.25% | -70.07% | -21.43% | -41.77% | -32.68% | 1.86% | -89.75% | -70.80% | -6.26% | -75.67% |
ARKK ARK Innovation ETF | -12.13% | 35.49% | 8.40% | 69.04% | -66.97% | -23.60% | 152.71% | 35.08% | 3.52% | 87.33% |
Returns By Period
In the year-to-date period, LABD achieves a -22.25% return, which is significantly lower than ARKK's -12.13% return. Over the past 10 years, LABD has underperformed ARKK with an annualized return of -57.45%, while ARKK has yielded a comparatively higher 14.34% annualized return.
LABD
- 1D
- -22.42%
- 1M
- -7.39%
- YTD
- -22.25%
- 6M
- -59.03%
- 1Y
- -82.24%
- 3Y*
- -55.49%
- 5Y*
- -38.61%
- 10Y*
- -57.45%
ARKK
- 1D
- 6.41%
- 1M
- -7.30%
- YTD
- -12.13%
- 6M
- -21.68%
- 1Y
- 42.06%
- 3Y*
- 19.10%
- 5Y*
- -10.73%
- 10Y*
- 14.34%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LABD vs. ARKK - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is higher than ARKK's 0.75% expense ratio.
Return for Risk
LABD vs. ARKK — Risk / Return Rank
LABD
ARKK
LABD vs. ARKK - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and ARK Innovation ETF (ARKK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LABD | ARKK | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.96 | 0.99 | -1.95 |
Sortino ratioReturn per unit of downside risk | -2.04 | 1.63 | -3.67 |
Omega ratioGain probability vs. loss probability | 0.77 | 1.19 | -0.42 |
Calmar ratioReturn relative to maximum drawdown | -0.91 | 1.24 | -2.15 |
Martin ratioReturn relative to average drawdown | -1.17 | 3.22 | -4.39 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LABD | ARKK | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.96 | 0.99 | -1.95 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.40 | -0.23 | -0.17 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.60 | 0.36 | -0.96 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.54 | 0.32 | -0.86 |
Correlation
The correlation between LABD and ARKK is -0.71. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Dividends
LABD vs. ARKK - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 5.82%, while ARKK has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 5.82% | 6.67% | 4.68% | 6.13% | 0.53% | 0.00% | 3.94% | 1.75% | 0.81% | 0.00% | 0.00% | 0.00% |
ARKK ARK Innovation ETF | 0.00% | 0.00% | 0.00% | 0.70% | 0.00% | 0.55% | 1.64% | 0.38% | 3.14% | 1.32% | 0.00% | 2.27% |
Drawdowns
LABD vs. ARKK - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.99%, which is greater than ARKK's maximum drawdown of -80.97%. Use the drawdown chart below to compare losses from any high point for LABD and ARKK.
Loading graphics...
Drawdown Indicators
| LABD | ARKK | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -80.97% | -19.02% |
Max Drawdown (1Y)Largest decline over 1 year | -88.09% | -31.35% | -56.74% |
Max Drawdown (5Y)Largest decline over 5 years | -97.73% | -77.23% | -20.50% |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | -80.97% | -19.01% |
Current DrawdownCurrent decline from peak | -99.99% | -56.23% | -43.76% |
Average DrawdownAverage peak-to-trough decline | -90.78% | -29.80% | -60.98% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 68.46% | 12.05% | +56.41% |
Volatility
LABD vs. ARKK - Volatility Comparison
Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 36.88% compared to ARK Innovation ETF (ARKK) at 12.71%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than ARKK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LABD | ARKK | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 36.88% | 12.71% | +24.17% |
Volatility (6M)Calculated over the trailing 6-month period | 59.06% | 27.59% | +31.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 87.11% | 42.61% | +44.50% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 96.40% | 46.38% | +50.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 96.40% | 40.12% | +56.28% |